MarketBeat aggregated consensus ratings and average price targets for Atour Lifestyle Holdings Limited. Morgan Stanley provided an overweight rating and price target.
3 reports, 2 independent
Updated Sat 00:00
No new developments lately
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat aggregated consensus ratings and average price targets for Atour Lifestyle Holdings Limited. Morgan Stanley provided an overweight rating and price target.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.HSBC upgraded Atour Lifestyle stock rating on October 10, 2026.1 source
MarketBeat aggregated analyst ratings and targets for Atour Lifestyle Holdings Limited; Morgan Stanley issued an overweight rating.1 source
Keep exploring
The entities involved
-
MarketBeat
American personal finance blog
-
Morgan Stanley
U.S. investment bank
- Mirum Pharmaceuticals received positive analyst rating updates, including buy ratings and raised price targets, from multiple firms including CLSA and Morgan Stanley.
- Goldman Sachs, Deutsche Bank, and Morgan Stanley provided market commentary on the SPX, with GS viewing market narrowness as not a warning sign.
Related events
- MarketBeat aggregated analyst ratings for SM Energy, noting an upgrade from Truist Financial and a rating change from Raymond James Financial.
- MarketBeat aggregated analyst ratings and price targets for LightPath Technologies, Inc. on May 27, 2026.
- MarketBeat has released its consensus rating and target price for Sunshine Biopharma, Inc.
- MarketBeat provided average ratings and consensus price targets for Eagle Bancorp Montana.
- Truist Financial raised its price target on CVS Health stock, with MarketBeat aggregating analyst ratings.